Skip to main content
Esc

Type to search

Articles / institutional-equities / Goldman says stocks like Nvidia have more room to run

Goldman says stocks like Nvidia have more room to run

BrightSpring Price Target
$71
Goldman Sachs' buy rating for BrightSpring Health Services includes a price target of $71.
Ulta Price Target
$652
Goldman Sachs maintains a price target of $652 for Ulta Beauty, indicating substantial potential upside.
Samsara Stock Growth
18%
Samsara's stock price has increased by 18% over the past month.

§ 01 Executive Snapshot

  • What: Goldman Sachs identifies several stocks poised for growth in the current market, including Nvidia, BrightSpring Health Services, Samsara, Ulta Beauty, and Johnson & Johnson.
  • Who: Key players include Goldman Sachs analysts Scott Fidel, Matthew Martino, and Kate McShane, along with the mentioned companies.
  • Why it matters: This analysis highlights potential investment opportunities and market trends, suggesting a favorable outlook for certain sectors despite broader market challenges.

§ 02 Key Developments

  • Goldman Sachs initiated coverage of BrightSpring Health Services with a buy rating and a price target of $71.
  • Samsara is viewed as one of the most defensible growth assets in software, with an 18% increase in stock price over the past month.
  • Ulta Beauty's stock price target remains at $652, indicating significant upside potential, despite a 23% decline in stock price this year.

§ 03 Strategic Context

  • The healthcare sector is evolving with companies like BrightSpring offering specialized services, positioning them for premium growth amid increasing demand for home-based care solutions.
  • The software industry is witnessing a consolidation trend, with firms like Samsara capitalizing on the need for integrated solutions in fleet management and connected operations.

§ 04 Strategic Implications

  • Immediate implications include increased investor interest in stocks identified by Goldman Sachs, potentially leading to upward price adjustments as market confidence builds.
  • Long-term, the strategies employed by these companies, particularly in healthcare and tech, could redefine competitive landscapes and drive sustained growth.

§ 05 Risks & Constraints

  • Potential risks include regulatory changes in healthcare that could impact companies like BrightSpring and Johnson & Johnson.
  • Competition in the software sector remains fierce, which could affect Samsara's market position despite its defensible growth attributes.

§ 06 Watchlist / Forward Signals

  • Key upcoming milestones include Samsara's investor day on June 24th, which could serve as a catalyst for stock performance.
  • Analysts will closely monitor Nvidia's capital allocation decisions and their effect on investor confidence and stock performance leading into 2027.
§ 07

Frequently Asked Questions

What stocks did Goldman Sachs identify as having growth potential?

Goldman Sachs identified Nvidia, BrightSpring Health Services, Samsara, Ulta Beauty, and Johnson & Johnson as stocks poised for growth.

Why is Samsara considered a defensible growth asset?

Samsara is viewed as one of the most defensible growth assets in software, with an 18% increase in stock price over the past month.

How does the healthcare sector impact companies like BrightSpring?

The healthcare sector is evolving, with companies like BrightSpring offering specialized services that position them for premium growth amid increasing demand for home-based care solutions.

When is Samsara's investor day and why is it significant?

Samsara's investor day is on June 24th, and it could serve as a catalyst for stock performance.

§ 08

Related Articles